←
Ofir Cohn16 posts
Ofir Cohn avatar

Ofir Cohn

@CohnOfir

Post-doctoral fellow | Sankaran Lab | Boston Children's Hospital | Broad Institute

◷ Joined April 2019▧ 8 Photos and videos
Anna-Lena Neehus avatar
⟳ Ofir Cohn retweeted
Anna-Lena Neehus@ALNeehus·Aug 7

Happy to share the preprints of two complimentary studies from my Postdoc with @bloodgenes: We set out to understand the mechanisms underlying inherited childhood B cell lymphoblastic leukemia (B-ALL): biorxiv.org/content/10.64898… biorxiv.org/content/10.64898…

Ofir Cohn avatar
Ofir Cohn@CohnOfir·Jun 2

Together, this study defines a key and underappreciated role of human DCs in mediating the consequences of inherited genetic variation on a range of complex disorders. (9/9).

Ofir Cohn avatar
Ofir Cohn@CohnOfir·Jun 2

Finally, we pinpointed a specific genetic variant in the PLD4 gene that drives pDC-specific predisposition to systemic lupus erythematosus (SLE) and other autoimmune disorders by increasing TLR7-mediated responses. (8/9)

Post attachmentPost attachment
Ofir Cohn avatar
Ofir Cohn@CohnOfir·Jun 2

Beyond cell-type associations, we constructed variant–gene maps to explore underlying regulatory mechanisms. We identified key genes involved in DC function. We showed that these risk variants exploit subset-specific networks to drive distinct pathogenic pathways. (7/9)

Post attachmentPost attachment
Ofir Cohn avatar
Ofir Cohn@CohnOfir·Jun 2

Next, we integrated fine-mapped variants from ~700 GWAS traits with our epigenomic profiles. We found novel associations between DC subpopulations and immune disorders, showing genetic risk preferentially targets specific subsets rather than distributing uniformly. (6/9)

Post attachment
Ofir Cohn avatar
Ofir Cohn@CohnOfir·Jun 2

For example, these analyses identified a negative regulatory relationship between the early regulatory factor ZEB2 and the late factor ID2 in cDC1s. By exploiting our HSPC-derived DC platform, we showed that perturbing ZEB2 dramatically increased cDC1s abundance. (5/9)

Post attachmentPost attachment
Ofir Cohn avatar
Ofir Cohn@CohnOfir·Jun 2

Prior DC studies primarily examined transcription. Leveraging paired multi-omics, we mapped the gene regulatory networks (GRNs) governing DC differentiation, revealing a transcriptional continuum of lineage-defining factors underlying late-stage development. (4/9)

Post attachmentPost attachment
Ofir Cohn avatar
Ofir Cohn@CohnOfir·Jun 2

By integrating our data with scRNA-seq from different organs and disease states, we showed that our in vitro system closely mirrors in vivo gene expression patterns with a cross-tissue conservation of DCs in both healthy and disease environments! (3/9)

Post attachment
Ofir Cohn avatar
Ofir Cohn@CohnOfir·Jun 2

DC abnormalities drive a wide spectrum of diseases. However, their rarity makes it challenging to link genetic risks to specific DC subsets and differentiation states. We profiled HSPC-derived DCs to generate a single-cell multi-omic atlas of their differentiation. (2/9)

Post attachment
Ofir Cohn avatar
Ofir Cohn@CohnOfir·Jun 2

Decades of research have revealed the intricacies of how dendritic cells (DCs) function, but fundamental questions remain about how this group of cells develops in humans and how this process goes awry in disease. A thread on our new work! (1/9) biorxiv.org/content/10.64898…

Post attachment
Ofir Cohn avatar
Ofir Cohn@CohnOfir·16 Aug 2022

Happy to share our recent study investigating the transcriptional landscape of the host when antecedent influenza infection followed by secondary Streptococcus pneumonia infection. #Influenza #streptococcus #superinfection biorxiv.org/content/10.1101/…

Ofir Cohn avatar
Ofir Cohn@CohnOfir·23 Mar 2022

We are very excited to share our new preprint now on #bioRxiv: Distinct gene programs underpinning 'disease tolerance' and 'resistance' in influenza virus infection biorxiv.org/content/10.1101/… @vikslab